Mathematical modeling of fungal infection in immune compromised individuals: The effect of back mutation on drug treatment

Journal of Theoretical Biology
Stephen WirkusPamela A Marshall

Abstract

We present a mathematical model that describes treatment of a fungal infection in an immune compromised patient in which both susceptible and resistant strains are present with a mutation allowing the susceptible strain to become resistant as well as a back mutation allowing resistant fungus to again become susceptible. The resulting nonlinear differential equations model the biological outcome, in terms of strain growth and cell number, when an individual is treated with a fungicidal or fungistatic drug. The model demonstrates that under any levels of the drug both strains will be in stable co-existence and high levels of treatment will never completely eradicate the susceptible strain. A modified model is then described in which the drug is changed to one in which both strains are susceptible, and subsequently, at the appropriate level of treatment, complete eradication of both fungal strains ensues. We discuss the model and implications for treatment options within the context of an immune compromised patient.

References

Feb 22, 1990·Journal of Theoretical Biology·F RodríguezJ R Medina
Aug 1, 1986·Journal of General Microbiology·D H HowardN Dabrowa
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Nov 1, 1994·The Journal of Antimicrobial Chemotherapy·D LawD W Denning
Feb 1, 1997·American Journal of Infection Control·F L Cohen, D Tartasky
Feb 29, 2000·Proceedings. Biological Sciences·S Gubbins, C A Gilligan
Mar 21, 2002·The Lancet Infectious Diseases·Dominique Sanglard, Frank C Odds
Jul 27, 2002·Annual Review of Microbiology·Leah E CowenLinda M Kohn
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley C Deresinski, David A Stevens
Jun 24, 2004·Bulletin of Mathematical Biology·Richard J HallChristopher A Gilligan
Jun 15, 2005·Nature Reviews. Microbiology·James B Anderson
Apr 7, 2006·Expert Review of Anti-infective Therapy·Vicki A Morrison
May 1, 2007·The Journal of Antimicrobial Chemotherapy·Marie-Thérèse BaixenchEric Dannaoui
Oct 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eyal RobenshtokMical Paul
Dec 15, 2007·Nature Reviews. Microbiology·Mihai G NeteaNeil A R Gow
Mar 8, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Herbert Hof
Aug 6, 2008·Annual Review of Phytopathology·Frank van den Bosch, Christopher A Gilligan
Apr 16, 2009·Clinical Microbiology Reviews·Richard D CannonBrian C Monk
May 19, 2009·Diagnostic Microbiology and Infectious Disease·Julianna FernandezDavid E Nix
May 5, 2011·Journal of Theoretical Biology·Erika T CamachoPamela A Marshall
Nov 10, 2013·PLoS Biology·Benjamin Matteson VincentSusan Lindquist

❮ Previous
Next ❯

Citations

Jun 30, 2021·Journal of Mathematical Biology·Avner Friedman, King-Yeung Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Central Nervous System Fungal Infections

Central nervous system fungal infections are rare and typically occur in immunocompromised patients, such as those with HIV infection or transplant recipients. Discover the latest research on central nervous system fungal infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.